{"id":292738,"date":"2024-11-29T16:28:35","date_gmt":"2024-11-29T16:28:35","guid":{"rendered":"https:\/\/www.artefact.com\/?post_type=blog&#038;p=292738"},"modified":"2024-12-18T07:46:42","modified_gmt":"2024-12-18T07:46:42","slug":"leaders-pov-accelerating-drug-innovation-through-ai-at-servier-ai-for-health-summit","status":"publish","type":"blog","link":"https:\/\/www.artefact.com\/br\/blog\/leaders-pov-accelerating-drug-innovation-through-ai-at-servier-ai-for-health-summit\/","title":{"rendered":"Ponto de vista dos l\u00edderes: Acelerando a inova\u00e7\u00e3o de medicamentos por meio da IA no SERVIER - AI for Health Summit"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_color: var(--awb-color6);--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-background-color:var(--awb-color1);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1 description\" style=\"--awb-text-color:var(--awb-color5);--awb-text-font-family:&quot;PT Serif&quot;;--awb-text-font-style:normal;--awb-text-font-weight:400;\"><p>Principais aprendizados do painel de discuss\u00e3o sobre \"Leaders' POV: Acelerando a inova\u00e7\u00e3o de medicamentos por meio da IA\", com Virginie Dominguez, vice-presidente executiva digital, Data e TI da Servier. <\/p>\n<p>Perguntas de Paul de Balincourt, Artefact Partner - Healthcare Data &amp; AI Transformation.<\/p>\n<\/div><\/div><\/div><\/div><\/div><article class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_color: var(--awb-color6);--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-background-color:var(--awb-color1);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-video fusion-youtube\" style=\"--awb-max-width:670px;--awb-max-height:377px;--awb-align-self:center;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.27%;\" ><iframe title=\"Reprodutor de v\u00eddeo do YouTube 1\" src=\"https:\/\/www.youtube.com\/embed\/32IRCaaMN1g?wmode=transparent&autoplay=0\" width=\"670\" height=\"377\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_2 1_2 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:10%;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-image-element\" style=\"text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\"fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/marketing.artefact.com\/l\/597421\/2024-12-11\/j39z22\" target=\"_self\" aria-label=\"S\u00ednteseAIFH-GIF\" rel=\"noopener\"><img decoding=\"async\" width=\"700\" height=\"404\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27700%27%20height%3D%27404%27%20viewBox%3D%270%200%20700%20404%27%3E%3Crect%20width%3D%27700%27%20height%3D%27404%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.artefact.com\/\/wp-content\/uploads\/2024\/11\/SyntheseAIFH-GIF.gif\" alt class=\"lazyload img-responsive wp-image-294955\"\/><\/a><\/span><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_2 1_2 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div ><a class=\"fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span fusion-button-default-type\" target=\"_self\" href=\"https:\/\/marketing.artefact.com\/l\/597421\/2024-12-11\/j39z22\" rel=\"noopener\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Baixar o relat\u00f3rio<\/span><\/a><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-2\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A Servier, uma empresa farmac\u00eautica global, tem como objetivo colocar os pacientes no centro de seus esfor\u00e7os de inova\u00e7\u00e3o. Historicamente reconhecida pela lideran\u00e7a em doen\u00e7as cardiovasculares e metab\u00f3licas, a Servier \u00e9 agora l\u00edder em oncologia, concentrando-se no desenvolvimento de tratamentos transformadores para c\u00e2nceres raros e de dif\u00edcil tratamento. Com base em seu modelo de oncologia, a empresa planeja estabelecer uma franquia de neurologia, estabelecendo metas ambiciosas para dobrar a probabilidade de sucesso e reduzir o tempo de coloca\u00e7\u00e3o no mercado em at\u00e9 quatro anos na pr\u00f3xima d\u00e9cada.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">O papel da IA na inova\u00e7\u00e3o de medicamentos<\/h2><\/div><div class=\"fusion-text fusion-text-3\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A descoberta de medicamentos \u00e9 um processo longo e dif\u00edcil, com uma taxa de sucesso abaixo de 5%. A Servier v\u00ea a IA como um facilitador essencial para acelerar a inova\u00e7\u00e3o e melhorar a efici\u00eancia. Os elementos essenciais para o sucesso incluem recursos computacionais robustos, data de alta qualidade e a atra\u00e7\u00e3o dos melhores talentos. No entanto, a escassez de data, especialmente para doen\u00e7as raras, continua sendo um desafio. As parcerias tamb\u00e9m s\u00e3o fundamentais, pois a inova\u00e7\u00e3o n\u00e3o pode ser alcan\u00e7ada isoladamente.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Abordagem em fases para a ado\u00e7\u00e3o da IA<\/h2><\/div><div class=\"fusion-text fusion-text-4\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A Servier abordou a ado\u00e7\u00e3o da IA em duas fases. Inicialmente, uma abordagem oportunista se concentrou em provar o potencial da IA por meio de casos de uso espec\u00edficos, especialmente em colabora\u00e7\u00e3o com as equipes de P&amp;D. Essa fase ajudou a preencher a lacuna cultural entre cientistas e especialistas em data. Agora, em uma fase sist\u00eamica, a Servier integra a IA em todos os processos de P&amp;D, identificando 16 pontos cr\u00edticos de dor e priorizando 20 iniciativas para maximizar o impacto e a viabilidade.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Conquistas em inova\u00e7\u00e3o orientada por IA<\/h2><\/div><div class=\"fusion-text fusion-text-5\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>As fases iniciais da pesquisa registraram avan\u00e7os significativos, principalmente na descoberta e valida\u00e7\u00e3o de alvos. A IA ajudou a identificar alvos de medicamentos de maior qualidade e simplificou os processos de design de medicamentos, incluindo mol\u00e9culas pequenas e terapias baseadas em nucleot\u00eddeos. O desenvolvimento cl\u00ednico se beneficiou do recrutamento mais r\u00e1pido de pacientes e da identifica\u00e7\u00e3o do centro de estudos. Em est\u00e1gios posteriores, a IA d\u00e1 suporte \u00e0 reda\u00e7\u00e3o m\u00e9dica, reduzindo significativamente o tempo gasto com a documenta\u00e7\u00e3o.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Solu\u00e7\u00f5es de IA na pr\u00e1tica<\/h2><\/div><div class=\"fusion-text fusion-text-6\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A Servier desenvolveu ferramentas internas que utilizam IA generativa para avalia\u00e7\u00e3o de alvos. Essas ferramentas processam um vasto data cient\u00edfico para avaliar a seguran\u00e7a do alvo, reduzindo a carga de trabalho dos cientistas em 9%. Essas solu\u00e7\u00f5es exemplificam como a IA aumenta, em vez de substituir, o conhecimento cient\u00edfico, possibilitando decis\u00f5es mais r\u00e1pidas e informadas no desenvolvimento de medicamentos.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Parcerias como pedra angular da inova\u00e7\u00e3o<\/h2><\/div><div class=\"fusion-text fusion-text-7\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A colabora\u00e7\u00e3o \u00e9 fundamental para a estrat\u00e9gia da Servier, tanto interna quanto externamente. Redes pr\u00e9-competitivas, como a associa\u00e7\u00e3o Feder, visam abordar desafios compartilhados em IA e desenvolvimento de medicamentos. A Servier tamb\u00e9m faz parcerias seletivas com empresas de ponta para g\u00eameos digitais e com a empresa francesa Owkin para imagens e aprendizado de m\u00e1quina. As colabora\u00e7\u00f5es p\u00fablico-privadas aceleram ainda mais o progresso, alavancando investimentos recentes significativos em pesquisa e inova\u00e7\u00e3o na Fran\u00e7a.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Conclus\u00e3o<\/h2><\/div><div class=\"fusion-text fusion-text-8\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>A integra\u00e7\u00e3o da IA da Servier na descoberta e no desenvolvimento de medicamentos demonstra seu compromisso com a inova\u00e7\u00e3o e o atendimento centrado no paciente. Embora os desafios permane\u00e7am, particularmente em torno do data e da aloca\u00e7\u00e3o de recursos, o foco estrat\u00e9gico da empresa em IA, parcerias e integra\u00e7\u00e3o sist\u00eamica a posiciona para liderar a transforma\u00e7\u00e3o dos resultados de sa\u00fade.<\/p>\n<\/div><\/div><\/div><\/div><\/article><\/p>","protected":false},"excerpt":{"rendered":"<p>A Servier abordou a ado\u00e7\u00e3o da IA em duas fases. Inicialmente, adotou-se uma abordagem oportunista, focada em comprovar o potencial da IA por meio de casos de uso espec\u00edficos, especialmente em colabora\u00e7\u00e3o com as equipes de P&amp;D.<\/p>","protected":false},"featured_media":292739,"parent":0,"template":"","meta":{"_acf_changed":false,"ep_exclude_from_search":false},"blog-category":[21931],"blog-language":[2991],"class_list":["post-292738","blog","type-blog","status-publish","has-post-thumbnail","hentry","blog-category-healthcare","blog-language-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/blog\/292738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/types\/blog"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/media\/292739"}],"wp:attachment":[{"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/media?parent=292738"}],"wp:term":[{"taxonomy":"blog-category","embeddable":true,"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/blog-category?post=292738"},{"taxonomy":"blog-language","embeddable":true,"href":"https:\/\/www.artefact.com\/br\/wp-json\/wp\/v2\/blog-language?post=292738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}